STAT

This brand-new advocacy group is an unapologetic defender of high drug prices

It’s not clear who funds this new advocacy group or when it officially launched, but it’s already clear which side of the drug pricing debate it’s on.

WASHINGTON — It’s less than a week old, but a shadowy new pharma advocacy group is already launching diatribes against advocates for lower drug prices, blasting pharmacy middlemen and defending even sky-high list prices for prescription drugs.

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readSociety
Opinion: Eliminating ‘Tensions’ In Health Care: A Litmus Test For Innovation
The challenge in applying the term innovation in health care is that the relationship between the "buyer" (patient) and the "seller" (provider) is convoluted by many other players.
STAT3 min readSociety
Opinion: Dreamers Like Me Fill Critical Gaps In Mental Health Care. The Dream And Promise Act Will Let Us Keep Doing That
Passing the American Dream and Promise Act to give Dreamers a pathway to citizenship would benefit not just the Dreamers but also the health care system and all of the…
STAT8 min read
Mental Health Apps Are Scooping Up Your Most Sensitive Data. Will You Benefit?
Mental health apps can put patients’ privacy at risk, and makers of some tools are using the data collected to create products that have nothing to do with health care.